EGFR and lung adenocarcinoma: Case Report: Partial Response Following Nivolumab Plus Docetaxel in a Patient With <i>EGFR</i> Exon 20 Deletion/Insertion (p.N771delinsGF) Mutant Lung Adenocarcinoma Transdifferentiated From Squamous Cell Carcinoma.